Initial experience on abdominal photon-counting computed tomography in clinical routine: general image quality and dose exposure

Whole-body CT scanning radiation improves the immune microenvironment of tumor tissues to enhance the antitumor effect of ICI

OBJECTIVE

The effect of frequent whole-body CT scans during immune checkpoint inhibitor (ICI) therapy on patients' anti-tumor immunity.

METHODS

We conducted a retrospective clinical study aimed to investigate the correlation between the frequency of CT scans during immune checkpoint inhibitor (ICI) therapy and the duration of remission (DOR) of ICI therapy in patients with stage IV non-small cell lung cancer (NSCLC). We constructed a hormonal mouse model and administered immune checkpoint inhibitor (ICI) therapy to mice, and radiated five whole-body CT scans to mice during ICI therapy to observe whether frequent whole-body CT scans had an effect on the antitumor effect of immunotherapy in mice.

RESULTS

The more frequent CT scans during patients' immune checkpoint inhibitor (ICI) treatment the longer the duration of remission (DOR) of ICI treatment. In a mouse model we observed that the addition of whole-body CT scanning radiation had a tendency to inhibit tumor growth in mice compared with the anti-PD-1 group alone.Frequent CT scanning radiation during the application of immune checkpoint inhibitor PD-1 increased the proportion of infiltrating CD8 + T cells in tumor tissues and significantly increased the proportion of IFNγ-secreting CD8 + T cells, and single-cell sequencing of the results also revealed that IFNγ and killing-related genes were significantly upregulated in tumor-infiltrating CD8T cells.

CONCLUSION

To our knowledge this is the first study on the effect of CT scan radiation on ICI.Our findings suggest that multiple CT scans during immune checkpoint inhibitor (ICI) treatment did not promote tumor progression, but instead a trend toward delayed tumor progression was observed.

Radiation from frequent whole-body CT scans induces systemic immunosuppression and immune activation of tumor tissue

OBJECTIVE

This study aims to elucidate the impact of repeated whole-body computed tomography (CT) scans on systemic immunity, the tumor immune microenvironment, and tumor control. This inquiry was prompted by clinical observations indicating a decrease in the levels of IFN-β and IFN-γ in patients' blood following whole-body CT scans.

METHODS

A Lewis lung carcinoma (LLC) mouse model was established and divided into two groups: a control group and a group subjected to multiple whole-body CT scanning radiation (WBCTSs). The study monitored tumor growth trends across both groups and employed a comprehensive set of analytical techniques-including enzyme-linked immunosorbent assay (ELISA), flow cytometry analysis, immunohistochemistry, RNA sequencing, and single-cell sequencing-to assess differences in cytokine profiles (IFN-β and IFN-γ), proportions of key immune cells, and gene expression variations between the groups.

RESULTS

Repeated CT scan radiation does not promote tumor progression. In tumor tissues subjected to multiple CT scans, an increase in the proportion of CD8+ T cells, elevated interferon levels, and up-regulation of genes associated with killing in CD8+ T cells and genes associated with Ifnb in macrophages were observed. In contrast, radiation from multiple whole-body CT scans resulted in a decrease in the proportion of CD8+ T cells in the blood and spleen, a decrease in serum interferon levels, and down-regulation of killing-related genes in CD8+ T cells.

CONCLUSION

Our results suggest that repeated whole-body CT scanning radiation induces systemic immunosuppression and immune activation in tumor tissues. Multiple repeated CT scans do not promote tumor progression.

Automated Kidney Stone Composition Analysis with Photon-Counting Detector CT, a Performance Study-A Phantom Study

BACKGROUND

For treatment of urolithiasis, the stone composition is of particular interest, as uric acid (UA) stones can be treated by chemolitholysis. In this ex vivo study, we employed an advanced composition analysis approach for urolithiasis utilizing spectral data obtained from a photon-counting detector CT (PCDCT) to differentiate UA and non-UA stones. Our primary objective was to assess the accuracy of this analysis method.

METHODS

A total of 148 urinary stones with a known composition that was measured by the standard reference method infrared spectroscopy (reference) were placed in an abdomen phantom and scanned in the PCDCT. Our objectives were to assess the stone detection rates of PCDCT and the accuracy of the prediction of the stone composition in UA vs non-UA compared to the reference.

RESULTS

Automated detection recognized 86.5% of all stones, with best detection rate for stones larger > 5 mm in diameter (95.4%, 88.8% for stones larger than 3 mm, 94.7% for stones larger than 4 mm). Depending on the volume, we found a recognition rate of 92.8% for stones larger than 20 mm3 and 94.0% for stones with more than 30 mm3. Prediction of UA composition showed an overall sensitivity and a positive predictive value of 66.7% and a specificity and negative predictive value of 94.5%. Best diagnostic values volume wise were found by only including stones with a larger volume than 30 mm3, there we found a sensitivity of 91.7%, and a specificity of 92.4%. Sensitivity in dependance of the largest diameter was best for stones larger than 5 mm (85.7%), but specificity decreased with increasing diameter (to 91.3%).

CONCLUSION

Automated urinary stone composition analysis with PCDCT showed a good automated detection rate of 86.5% up to 95.4% depending on stone diameter. The differentiation between non-UA and UA stones is performed with an NPV of 94.5% and a PPV of 66.7%. The prediction probability of non-UA stones was very good. This means the automatic detection and differentiation algorithm can identify the patients which will not profit from chemolitholysis.

Routine CT Diagnostics Cause Dose-Dependent Gene Expression Changes in Peripheral Blood Cells

The increasing use of computed tomography (CT) has led to a rise in cumulative radiation dose due to medical imaging, raising concerns about potential long-term adverse effects. Large-scale epidemiological studies indicate a higher tumor incidence associated with CT examinations, but the underlying biological mechanisms remain largely unexplained. To gain further insights into the cellular response triggered by routine CT diagnostics, we investigated CT-induced changes of gene expression in peripheral blood cells using whole transcriptome sequencing. RNA was isolated from peripheral blood cells of 40 male patients with asymptomatic microhematuria, sampled before and after multi-phase abdominal CT (CTDIvol: 3.75-26.95 mGy, median: 6.55 mGy). On average, 22.11 million sequence reads (SD 5.71) per sample were generated to identify differentially expressed genes 6 h post-exposure by means of DESeq2. To assess the dose dependency of CT-induced effects, we additionally divided samples into three categories: low exposure (≤6.55 mGy, n = 20), medium exposure (>6.55 mGy and <12 mGy, n = 16), and high exposure (≥12 mGy, n = 4), and repeated gene expression analysis for each subset and their corresponding prae-exposure sample. CT exposure caused consistent and dose-dependent upregulation of six genes (EDA2R, AEN, FDXR, DDB2, PHLDA3, and MIR34AHG; padj < 0.1). These genes share several functional commonalities, including regulation by TP53 and involvement in the DNA damage response. The biological pathways highlighted by Gene Set Enrichment Analysis (GSEA) suggest a dose-dependent increase of cellular damage and metabolic particularities in the low-exposure subset, which may be related to a potential adaptive cellular response to low-dose irradiation. Irrespective of applied dose, AEN emerged as the most robust biomarker for CT exposure among all genes. Routine abdominal CT scans cause dose-dependent gene deregulation in association with DNA damage in peripheral blood cells after in vivo exposure. Regarding risk assessment of CT, our results support the commonly applied "As Low-As -Reasonably Achievable (ALARA)" principle. Evidence of additional gene expression changes associated with metabolic processes indicates a rather complex molecular response beyond DNA damage after CT exposure, and emphasizes the need for further targeted investigations.

Comparison of Radiation Dose and Image Quality in Pediatric Abdominopelvic Photon-Counting Versus Energy-Integrating Detector CT

OBJECTIVE

Adoption of abdominal photon counting detector CT (PCD-CT) into clinical pediatric CT practice requires evidence that it provides diagnostic images at acceptable radiation doses. Thus, this study aimed to compare radiation dose and image quality of PCD-CT and conventional energy-integrating detector CT (EID-CT) in pediatric abdominopelvic CT.

MATERIALS AND METHODS

This institutional review board-approved retrospective study included 147 children (median age 8.5 y; 80 boys, 67 girls) who underwent clinically indicated contrast-enhanced abdominopelvic PCD-CT between October 1, 2022 and April 30, 2023 and 147 children (median age 8.5 y; 74 boys, 73 girls) who underwent EID-CT between July 1, 2021 and January 1, 2022. Patients in the 2 groups were matched by age and effective diameter. Radiation dose parameters (CT dose index volume, CTDIvol; dose length product, DLP; size-specific dose estimate, SSDE) were recorded. In a subset of 25 matched pairs, subjective image quality was assessed on a scale of 1 to 4 (1=highest quality), and liver attenuation, dose-normalized noise, and contrast-to-noise ratio (CNR) were measured. Groups were compared using parametric and/or nonparametric testing.

RESULTS

Among the 147 matched pairs, there were no significant differences in sex (P=0.576), age (P=0.084), or diameter (P=0.668). PCD-CT showed significantly lower median CTDIvol, DLP, and SSDE (1.6 mGy, 63.8 mGy-cm, 3.1 mGy) compared with EID-CT (3.7 mGy, 155.3 mGy-cm, 6.0 mGy) (P<0.001). In the subset of 25 patients, PCD-CT and EID-CT showed no significant difference in overall image quality for reader 1 (1.0 vs. 1.0, P=0.781) or reader 2 (1.0 vs. 1.0, P=0.817), or artifacts for reader 1 (1.0 vs. 1.0, P=0.688) or reader 2 (1.0 vs. 1.0, P=0.219). After normalizing for radiation dose, image noise was significantly lower with PCD-CT (P<0.001), while CNR in the liver (P=0.244) and portal vein (P=0.079) were comparable to EID-CT.

CONCLUSION

Abdominopelvic PCD-CT in children significantly reduces radiation dose while maintaining subjective image quality, and accounting for dose levels, has the potential to lower image noise and achieve comparable CNR to EID-CT. These data expand understanding of the capabilities of PCD-CT and support its routine use in children.

Virtual non-contrast images in photon-counting computed tomography: impact of different contrast phases

BACKGROUND

Photon-counting computed tomography (PCCT) enables new ways of image reconstruction, e.g. material decomposition and creation of virtual non-contrast (VNC) series with higher resolution and lower radiation dose than standard computed tomography (CT). Clinical experiences of this are limited.

PURPOSE

To compare true non-contrast (TNC) series with VNC series derived from non-enhanced (VNCu), arterial phase (VNCa) and portal venous phase (VNCv) in clinically approved PCCT.

MATERIAL AND METHODS

A total of 45 clinical, tri-phasic abdominal CT scans from the PCCT Naetom Alpha, between February 2022 and November 2022, were retrospectively assessed. Placing a region of interest in six different locations in each VNC series - right liver parenchyma, left liver parenchyma, spleen, aorta, erector spinae muscle, and in the subcutaneous fat - absolute Hounsfield values (HU) and standard deviations (SD) were collected. Differences in HU (ΔHU) were compared and statistically analyzed.

RESULTS

Statistically significant differences between VNC and TNC were seen in all measurements, with the largest difference in the subcutaneous fat and the smallest difference in the erector spinae muscle. Only small differences were seen between VNCa and VNCv, where the largest differences were seen in the left and right liver lobes.

CONCLUSION

VNC images from the first-generation clinically approved PCCT showed a significant difference between VNC and TNC images. The differences vary with the type of tissue. Only small differences were seen depending from which contrast phase the VNC was derived.

Cardiac computed tomography with late contrast enhancement: A review

Cardiac computed tomography (CCT) has assumed an increasingly significant role in the evaluation of coronary artery disease (CAD) during the past few decades, whereas cardiovascular magnetic resonance (CMR) remains the gold standard for myocardial tissue characterization. The discovery of late myocardial enhancement following intravenous contrast administration dates back to the 1970s with ex-vivo CT animal investigations; nevertheless, the clinical application of this phenomenon for cardiac tissue characterization became prevalent for CMR imaging far earlier than for CCT imaging. Recently the technical advances in CT scanners have made it possible to take advantage of late contrast enhancement (LCE) for tissue characterization in CCT exams. Moreover, the introduction of extracellular volume calculation (ECV) on cardiac CT images combined with the possibility of evaluating cardiac function in the same exam is making CCT imaging a multiparametric technique more and more similar to CMR. The aim of our review is to provide a comprehensive overview on the role of CCT with LCE in the evaluation of a wide range of cardiac conditions.

Ultra-low-dose photon-counting CT of paranasal sinus: an in vivo comparison of radiation dose and image quality to cone-beam CT

PURPOSE

This study investigated the differences in subjective and objective image parameters as well as dose exposure of photon-counting CT (PCCT) compared to cone-beam CT (CBCT) in paranasal sinus imaging for the assessment of rhinosinusitis and sinonasal anatomy.

METHODS

This single-centre retrospective study included 100 patients, who underwent either clinically indicated PCCT or CBCT of the paranasal sinus. Two blinded experienced ENT radiologists graded image quality and delineation of specific anatomical structures on a 5-point Likert scale. In addition, contrast-to-noise ratio (CNR) and applied radiation doses were compared among both techniques.

RESULTS

Image quality and delineation of bone structures in paranasal sinus PCCT was subjectively rated superior by both readers compared to CBCT (P < .001). CNR was significantly higher for photon-counting CT (P < .001). Mean effective dose for PCCT examinations was significantly lower than for CBCT (0.038 mSv ± 0.009 vs. 0.14 mSv ± 0.011; P < .001).

CONCLUSION

In a performance comparison of PCCT and a modern CBCT scanner in paranasal sinus imaging, we demonstrated that first-use PCCT in clinical routine provides higher subjective image quality accompanied by higher CNR at close to a quarter of the dose exposure compared to CBCT.

Reducing radiation dose for NN-based COVID-19 detection in helical chest CT using real-time monitored reconstruction

Computed tomography is a powerful tool for medical examination, which plays a particularly important role in the investigation of acute diseases, such as COVID-19. A growing concern in relation to CT scans is the radiation to which the patients are exposed, and a lot of research is dedicated to methods and approaches to how to reduce the radiation dose in X-ray CT studies. In this paper, we propose a novel scanning protocol based on real-time monitored reconstruction for a helical chest CT using a pre-trained neural network model for COVID-19 detection as an expert. In a simulated study, for the first time, we proposed using per-slice stopping rules based on the COVID-19 detection neural network output to reduce the frequency of projection acquisition for portions of the scanning process. The proposed method allows reducing the total number of X-ray projections necessary for COVID-19 detection, and thus reducing the radiation dose, without a significant decrease in the prediction accuracy. The proposed protocol was evaluated on 163 patients from the COVID-CTset dataset, providing a mean dose reduction of 15.1% while the mean decrease in prediction accuracy amounted to only 1.9% achieving a Pareto improvement over a fixed protocol.